Allan T van Oosterom
Overview
Explore the profile of Allan T van Oosterom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
2712
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rutkowski P, Van Glabbeke M, Rankin C, Ruka W, Rubin B, Debiec-Rychter M, et al.
J Clin Oncol
. 2010 Mar;
28(10):1772-9.
PMID: 20194851
Purpose: Dermatofibrosarcoma protuberans (DFSP) is a dermal sarcoma typically carrying a translocation between chromosomes 17 and 22 that generates functional platelet-derived growth factor B (PDGFB). Patients And Methods: Two distinct...
2.
Baudin E, Droz J, Paz-Ares L, van Oosterom A, Cullell-Young M, Schlumberger M
Am J Clin Oncol
. 2009 Aug;
33(1):83-8.
PMID: 19704366
Objectives: To evaluate the antitumor response, time-to-event efficacy endpoints and toxicity of plitidepsin (Aplidin) 5 mg/m as a 3-hour intravenous (i.v.) infusion every 2 weeks in patients with unresectable advanced...
3.
Ceulemans J, De Wever I, Sciot R, Debiec-Rychter M, van Oosterom A
Sarcoma
. 2008 Jun;
6(4):135-9.
PMID: 18521350
We report the case of a 66-year-old man presenting with a high-grade pleomorphic sarcoma at the left elbow 16 years after the extravasation of adriamycin given for a malignant ifbrous...
4.
Schoffski P, Dumez H, Wolter P, Stefan C, Wozniak A, Jimeno J, et al.
Expert Opin Pharmacother
. 2008 Jun;
9(9):1609-18.
PMID: 18518789
Background: Patients with advanced or metastatic non-gastrointestinal stromal tumour soft tissue sarcoma (STS) whose disease progresses during or after chemotherapy with doxorubicin or ifosfamide have few options and very limited...
5.
Maes T, Wildiers H, Heye S, Demey W, Maleux G, Neven P, et al.
Breast Cancer Res Treat
. 2007 Sep;
110(1):135-42.
PMID: 17851764
Background: In the treatment of extensive liver metastasis of breast cancer (LMBC), locally administered Mitomycin C (MMC) to the liver might be an effective approach with limited toxicity. Patients And...
6.
Proteomics in cancer research: methods and application of array-based protein profiling technologies
Hoeben A, Landuyt B, Botrus G, De Boeck G, Guetens G, Highly M, et al.
Anal Chim Acta
. 2007 Aug;
564(1):19-33.
PMID: 17723358
With the human genome sequence now determined, the field of molecular medicine is moving beyond genomics to proteomics, the large-scale analysis of proteins. It is now possible to examine the...
7.
Baur M, van Oosterom A, Dieras V, Tubiana-Hulin M, Coombes R, Hatschek T, et al.
J Cancer Res Clin Oncol
. 2007 Jul;
134(2):125-35.
PMID: 17636328
The efficacy and tolerability of docetaxel 100 mg/m(2) every 3 weeks as second-line chemotherapy in patients with metastatic breast cancer was investigated. In addition, the efficacy of a 3-day prophylaxis...
8.
Prenen H, Dumez H, Stefan C, Hoeben A, Wouters C, van Lierde M, et al.
Acta Gastroenterol Belg
. 2007 Mar;
69(4):367-71.
PMID: 17343077
Background: Gastrointestinal stromal tumours (GIST) are the most common mesenchymal tumours of the gastrointestinal tract. They are defined immunohistologically as KIT positive tumours. The only effective treatment for malignant GIST...
9.
Verweij J, Casali P, Kotasek D, Cesne A, Reichard P, Judson I, et al.
Eur J Cancer
. 2007 Mar;
43(6):974-8.
PMID: 17336514
Recent publications have suggested that imatinib (Glivec) may be cardiotoxic. We have therefore assessed the largest study on the agent performed in patients with gastrointestinal stromal tumours, randomising a daily...
10.
Dumez H, Gall H, Capdeville R, Dutreix C, van Oosterom A, Giaccone G
Anticancer Drugs
. 2006 Dec;
18(2):219-25.
PMID: 17159608
LAF389 is a synthetic analogue of bengamide B, a natural product isolated from Jaspidae sponges. LAF389 has both antiproliferative and antiangiogenetic properties, and preclinical investigations showed a broad antitumour activity....